Patents by Inventor Colleen E. Hayes

Colleen E. Hayes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTERING PULSE DOSE CALCITRIOL
    Publication number: 20090221538
    Abstract: Prophylactic or therapeutic treatment to inhibit the development or progress of multiple sclerosis symptoms is provided by providing intermittently administered elevated doses of calcitriol, sufficiently infrequently to avoid hypercalcemia. Such methods may include maintaining at least about a normal blood level of vitamin D3 as evidenced by a 25-(OH)D3 level of at least about 50 nmol/L.
    Type: Application
    Filed: February 2, 2009
    Publication date: September 3, 2009
    Inventors: Colleen E. Hayes, Richard Derks, Faye E. Nashold
  • Treating vitamin D responsive diseases
    Patent number: 6989377
    Abstract: The present invention relates to therapeutics for the prevention and treatment of vitamin D responsive diseases in humans, as well as other animals, through the use of biologically active vitamin D compounds in combination with at least one other immunomodulatory compound such as interleukin-10, interleukin-4, or a TNF? inhibitor.
    Type: Grant
    Filed: June 13, 2002
    Date of Patent: January 24, 2006
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
    Patent number: 6858595
    Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: February 22, 2005
    Assignee: Wisconsin Alumni Research Association
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Treating vitamin D responsive diseases
    Publication number: 20030109506
    Abstract: The present invention relates to therapeutics for the prevention and treatment of vitamin D responsive diseases in humans, as well as other animals, through the use of biologically active vitamin D compounds in combination with at least one other immunomodulatory compound such as interleukin-10, interleukin-4, or a TNF&agr; inhibitor.
    Type: Application
    Filed: June 13, 2002
    Publication date: June 12, 2003
    Applicant: Northern Lights Pharmaceuticals, LLC
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
    Publication number: 20020128241
    Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 12, 2002
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
    Patent number: 6358939
    Abstract: Methods of treating inflammatory bowel disease are described, and in particular the prevention and treatment of inflammatory bowel disease in humans as well as other animals. These methods involve the administration of biologically active vitamin D compounds, and therapeutic compositions thereof, so that the symptoms of Inflammatory Bowel Disease are reduced or relieved.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: March 19, 2002
    Assignee: Northern Lights Pharmaceuticals, LLC
    Inventors: Colleen E. Hayes, Faye E. Nashold
  • Use of vitamin D compounds to prevent transplant rejection
    Patent number: 6071897
    Abstract: A method of moderating transplant rejection in a transplant recipient comprising administering a dose of vitamin D compound effective to prevent transplant rejection is disclosed. Preferably, the recipient's susceptibility to opportunistic infections has not been compromised. Also preferably, the recipient has not suffered bone demineralization.
    Type: Grant
    Filed: July 15, 1998
    Date of Patent: June 6, 2000
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. DeLuca, Margherita T. Cantorna, Colleen E. Hayes, Debra A. Hullett, Hans W. Sollinger, Jean Humpal-Winter
  • Treatment of arthritic disease induced by infectious agents
    Patent number: 5891865
    Abstract: A method of treating arthritis symptoms induced by an infectious agent of an arthritis patient comprising administering to an arthritis patient an amount of vitamin D compound effective to reduce symptoms and observing a reduction in symptoms is disclosed.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: April 6, 1999
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. DeLuca, Margherita T. Cantorna, Colleen E. Hayes
  • Multiple sclerosis treatment
    Patent number: 5716946
    Abstract: A method of treating the multiple sclerosis symptoms of a multiple sclerosis patient is disclosed comprising administering to a multiple sclerosis patient an amount of a vitamin D compound effective to reduce symptoms and to enable an observation of a reduction in symptoms.
    Type: Grant
    Filed: February 13, 1996
    Date of Patent: February 10, 1998
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Hector F. DeLuca, Colleen E. Hayes, Margherita T. Cantorna